Pheno Therapeutics Ltd
Martin Quibell is a highly experienced scientist with a background in medicinal chemistry. Martin has held various leadership positions in pharmaceutical and biotechnology companies, and has a proven track record of innovation and success in drug discovery. Currently, Martin is involved in multiple ventures focused on developing novel therapeutics for a range of medical conditions, including Huntington's disease and cancer. Martin's expertise and contributions have been instrumental in advancing the field of drug development.
This person is not in any teams
This person is not in any offices
Pheno Therapeutics Ltd
Drug discovery for small molecules promoting remyelination in multiple sclerosis